STRO
Sutro Biopharma
15.70$
-2.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
Sutro Biopharma (STRO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -38 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -34 | 14 | -65 | 9.5 | -65 | -72 | -68 | -45 | -38 | -26 | -42 | -38 | -145 | |
| 1.7 | 1.7 | 1.8 | 1.8 | 1.8 | 1.9 | 1.9 | 1.9 | 1.9 | 1.6 | 1.3 | 1.3 | 6.1 | |
| 6.0 | 6.2 | 6.1 | 6.2 | 6.5 | 5.9 | 5.5 | 5.3 | 1.6 | 1.7 | 1.6 | 2.0 | 6.8 | |
| 3.7 | -22 | -17 | 48 | -7.1 | -16 | -9.1 | -51 | 4.6 | 4.7 | -17 | -14 | -21 | |
| 0.3 | 1.4 | 0.4 | 0.8 | 0.8 | 1.1 | 1.2 | 0.1 | 0.3 | 0.2 | 0.0 | 0.0 | 0.4 | |
| -114 | -24 | 64 | -80 | 147 | 87 | -16 | 2.6 | 40 | 19 | -45 | 19 | 33 | |
| 0.0 | 0.5 | -0.4 | 0.0 | 0.4 | 0.0 | – | -0.1 | – | – | – | 0.2 | – | |
| – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | |
| -5.7 | -3.1 | -3.4 | 96 | 1.0 | 0.0 | 0.1 | -0.1 | 0.1 | -0.1 | 103 | -0.4 | 103 | |
| -153 | -13 | -4.1 | 26 | 84 | 16 | -84 | -42 | 1.9 | -7.8 | 16 | -19 | -9.7 | |
| -34 | 13 | -65 | 8.7 | -65 | -73 | -69 | -45 | -38 | -27 | -42 | -38 | -146 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.